Go to content

News & Insights

Filters

Changing any of the form inputs will cause the content to refresh with the filtered results.

Skip filters

Acuitas Therapeutics named one of BC’s Top Employers of 2025

Read about Acuitas Therapeutics named one of BC’s Top Employers of 2025

PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays

Read about PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays

PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by  in situ delivery of RNA lipid nanoparticles

Read about PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by  in situ delivery of RNA lipid nanoparticles

Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit

Read about Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit

Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone

Read about Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone

Acuitas Therapeutics Honoured With Philanthropic Award

Read about Acuitas Therapeutics Honoured With Philanthropic Award

Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference

Read about Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference

PUBLICATION ALERT: Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA

Read about PUBLICATION ALERT: Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA

Christopher Sweeney Named Executive Director, Intellectual Property

Read about Christopher Sweeney Named Executive Director, Intellectual Property

Acuitas Poster Presentations at ASGCT Annual Meeting

Read about Acuitas Poster Presentations at ASGCT Annual Meeting

Acuitas Therapeutics Named One of Canada’s Top Small & Medium Employers of 2024

Read about Acuitas Therapeutics Named One of Canada’s Top Small & Medium Employers of 2024

Acuitas Therapeutics Named One of BC’s Top Employers of 2024

Read about Acuitas Therapeutics Named One of BC’s Top Employers of 2024